An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma.

Hao YangGuanglin LeiZhuoya DengFang SunYuying TianJinxia ChengHongyu YuCong LiChangqing BaiShaogeng ZhangGuangwen AnPenghui Yang

Published in: Journal of hepatocellular carcinoma (2024)

Taken together, our findings demonstrate the novel chimeric influenza OV could provide a potential therapeutic strategy for combating HCC and improve the effectiveness of virotherapy for cancer therapy.

Keyphrases

cancer therapy
cell therapy
drug delivery
randomized controlled trial
systematic review
stem cells
low density lipoprotein
mesenchymal stem cells
bone marrow